Equitable Holdings closed the week at $44.04, up 5.3% over five days and 16.5% over the past month. The catalyst was a Q1 earnings beat that sent the stock 4.4% higher in a single session — and immediately pulled in a round of upward analyst revisions.
The Street's reaction to Q1 results was quick and directionally consistent. Keefe, Bruyette & Woods lifted its target to $60 from $51 just one day after the print, maintaining its Outperform. Barclays moved its target to $51 from $49, also keeping Overweight. Both followed earlier April moves that had cut targets into the tariff-anxiety sell-off — KBW had trimmed to $51 from $53 on April 10, Barclays to $49 from $57 on April 8. The reversals tell the story concisely: the macro fear was priced in, results cleared it. The consensus is firmly buy-leaning, with nine buy-equivalent ratings, a mean target near $57.50, and roughly 31% implied upside from here. EPS surprise ranks in the 86th percentile across the universe — a consistent pattern of beating estimates that underpins the analyst confidence.
The short position has been retreating alongside the price recovery, and the current setup offers no meaningful short-side tension. Short interest has dropped roughly 14% over the past month, landing at around 2.3% of the free float — a level too small to drive squeeze dynamics or frame a short-side narrative. The borrow market confirms the lack of urgency: cost to borrow is running at under 0.5%, and availability remains loose. The short score of 30.8 is well into neutral territory. Put/call ratio at 1.50 is actually running below its 20-day mean of 1.77, a mild drift away from the defensive posture that had built through March and early April when the ratio sat above 2.0. Options positioning has relaxed, not tightened, on the back of better results — itself a small but readable signal.
The insider picture adds one complicating thread. CEO Mark Pearson sold approximately $1.65 million worth of shares on April 20, his second meaningful sale within a fortnight — a roughly $1.53 million disposal came on April 8. COO Jeffrey Hurd was also active on April 15, selling across three separate transactions. The net 90-day insider value sold is over $20 million. These are plan-driven or compensation-related sales more likely than directional bets, but the cluster of executive disposals — concentrated in the $40–$42 range just before a 6% one-day pop — is worth flagging as context. At $44 the stock now trades above every one of those transaction prices.
The peer picture is split this week. Closest correlate CRBG edged up 0.4% on the week — roughly flat — while JXN fell 6.1% and APO added 5.4%. EQH outran the peer group on both a one-day and one-week basis, which reinforces that the Q1 results were a company-specific catalyst rather than a sector lift. Market cap runs at roughly $11.6 billion, placing EQH firmly in large-cap financial services territory, and the forward yield of 2.79% provides a modest income floor.
The next earnings date is July 30. Between now and then, the central question is whether the analyst target-raise cycle has further to run — the gap between current price ($44) and consensus target ($57.50) is wide enough to sustain buying interest, but the short-covering-driven acceleration phase is likely complete given SI is already near its lowest level in six weeks.
See the live data behind this article on ORTEX.
Open EQH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
